Exploring T Activation via Buffy Coat Samples in Psychiatry

D

Dr. Jon Berner's discussion in the Longevity & Aging Series, Aging-US, October 23, 2024.

Mental HealthTesting

Quotes From Source

“Buffy coat samples from 30 women in a psychiatric clinic...”

Story of claim

Dr. Jon Berner discusses using Buffy coat samples to explore T cell activation in psychiatric populations, aiming to correlate with psychiatric conditions.

  • Goal: Investigating T cell activation as a marker for psychiatric conditions.
  • Proof: Study found consistent findings with known biology in a psychiatric population using Buffy coat samples.
  • Nuances:
    • 30 women from a psychiatric clinic, not normal controls.
    • Phosphorylation of S6 Kinase used as surrogate measure.
  • Impact on Life: Potentially offers new markers for diagnosing psychiatric conditions, aiding in personalized treatment plans.

Investments

  • Price: Research study costs vary widely.
  • Time: Pilot study, future research needed for validation.
  • Effort: Requires access to specialized research facilities.

Risks

Pilot study limitations include small sample size and limited generalizability.

Alternatives

  • Other biomarkers for psychiatric conditions
  • Traditional clinical diagnostic methods

Get Started 🚀

  • Collaborate with research institutions.
  • Secure ethical approvals for human samples.
  • Conduct pilot studies with psychiatric populations.

Brogevity AI can make mistakes. Check important info.

Reference Video